Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

NCT01410227 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Von Willebrand Disease

Interventions

BIOLOGICAL: Recombinant von Willebrand factor (rVWF)
DRUG: Placebo
BIOLOGICAL: Recombinant factor VIIII (rFVIII)

Sponsor

Baxalta now part of Shire